Radiation Therapist I/II — MRIdian & Advanced Therapy

City of Hope; Irvine (CA); On-site; USD 73,000 - 117,000; Full time

Benefits offered by this job

Sign-on Bonus

Job summary

City of Hope in Irvine, CA is seeking a Radiation Therapist I/II to join our Radiation Oncology team. You will deliver prescribed radiation therapy, operate MRI simulation equipment, and work with MRIdian MR Linac and Varian Ethos systems.

New grads are welcome; this role offers training, diverse procedures (IMRT, SRS, SBRT, TBI, HDR), and opportunities to contribute to compassionate cancer care while ensuring patient safety and high-quality dosimetry.

Qualifications

• High School or equivalent; Post High School Vocational/Specialized Training in an accredited Radiation Therapy Education Program.
• Graduate of an accredited radiologic technology course plus radiation therapy course OR Graduate of an accredited Bachelor of Science in Radiation Therapy Program.
• Licensed by the California State Department of Health (Certified in Radiation Therapy).
• ARRT certification in Radiation Therapy CRT.
• BLS or CPR.

Responsibilities

• Deliver prescribed and planned radiation therapy to patients of all ages.
• Operate MRI control console for each patient’s scan and select imaging techniques.
• Reinforce treatment-related guidance and manage side effects.
• Perform simulation procedures and assist in dosimetry.
• Perform diagnostic testing on equipment and conduct quality assurance.
• Experience with Aria is highly preferred.

Skills

Licensure

ARRT CRT

BLS/CPR

Education

High School

Radiation Therapy Program

Bachelor in Radiation Therapy

Tools

MRIdian MR Linac

Varian Ethos

ARIA

Job description

City of Hope in Irvine, CA is seeking a Radiation Therapist I/II to join our Radiation Oncology team. You will deliver prescribed radiation therapy, operate MRI simulation equipment, and work with MRIdian MR Linac and Varian Ethos systems.

New grads are welcome; this role offers training, diverse procedures (IMRT, SRS, SBRT, TBI, HDR), and opportunities to contribute to compassionate cancer care while ensuring patient safety and high-quality dosimetry.